R&D Pipeline
Syntopix has over 1,400 compounds in its library. The most advanced lead compounds are now entering commercialisation.
Recent News
06/08/2008 13:13
Syntopix proposal to raise £1.5million passed by shareholders...
03/07/2008 07:00
Syntopix enters into joint development agreement with Procter & Gamble...
25/02/2008 07:00
Syntopix announces positive results from its Phase II cosmetic study...